Lymphoma

Whether you're looking to be treated, or just want a second opinion, Nebraska Medicine matches you up with a world-renowned lymphoma team. With an unsurpassed reputation for care, we treat patients from 5 continents and all 50 states treating all forms of lymphoma and offering the most advanced treatment options including blood and marrow transplantation. Patients are also offered participation in the latest leading edge lymphoma clinical trials conducted by the University of Nebraska Medical Center. Discoveries made in laboratories are implemented into personalized lymphoma treatment plans, improving success rates and outcomes.

The Best Place for Cancer Care

The Fred & Pamela Buffett Cancer Center consists of a 10-story, 98-laboratory research tower named the Suzanne and Walter Scott Cancer Research Tower; an eight-story, 108-bed inpatient treatment center named the C.L. Werner Cancer Hospital; and a multidisciplinary outpatient center. With a comprehensive team of more than 200 cancer experts covering all specialties across the cancer spectrum, there is no need for people to travel outside the region for cancer care.

The Highest Level of Treatment Methods

Our world renowned lymphoma team works with you to determine the best possible care plan tailored to meet your needs.Treatments may include:

• Leading Edge Clinical Trials
• Chemotherapy
• Chimeric Antigen Receptor (CAR) T-Cell Therapy
• Immunotherapy
• Monoclonal Antibodies
• Targeted Therapies - these are drugs designed to target specific genes or proteins in types of cancer cells that spread the cancer.
• Radiation Therapy
• Blood and Bone Marrow Transplant

Experience

There are many types of lymphomas and each requires a customized treatment plan. Our dedicated team of lymphoma experts uses the latest diagnostics, and treatment options including leading edge clinical trials and bone and blood marrow transplants. Our lymphoma team averages 150 to 160 bone and blood marrow transplants a year and have performed more than 4,800 transplants since the program's founding.

Ground-Breaking Advancements

Doctors and researchers at Nebraska Medicine have been pioneers in the field and are recognized internationally for a number of ground-breaking advancements. Our innovative treatments have helped improve success rates and have made blood and marrow transplants a more viable and promising option for a growing number of patients. Doctors from around the world call upon Nebraska Medicine’s lymphoma team for consultation and to collaborate for patient care.

Expertise Near You

The Nebraska Lymphoma Study Group (NLSG) brings community oncologists, pathologists and their counterparts together to provide the very best in lymphoma treatment while giving patients the opportunity to stay close to home. Nearly 6,500 patients have been treated and more than 65,000 biopsies reviewed since the study group was formed in 1982.

A Team Approach

With the many different types of lymphoma, it is imperative that your cancer be properly identified so doctors can formulate the best treatment plan for you. To precisely diagnose and treat your cancer, our hematopathologists - who are sought after nationally for their expertise - will carefully determine your specific type of lymphoma along with your team of specialists that may include medical oncologists, radiation oncologists, surgical oncologists, advanced practice providers, nursing and more. This team meets regularly to discuss your case and to develop a coordinated and personalized plan of care.

Care When You Need It Most

All patients undergoing cancer treatment with Nebraska Medicine have access to our Infusion Center at the Fred & Pamela Buffett Cancer Center, which serves as a treatment center and urgent-care-type facility for those battling cancer.

Clinical Trials

Access to clinical trials affords patients the ability to participate in leading edge treatments that otherwise would not be available to them. New approaches for Hodgkin lymphoma are being study through clinical trials at Nebraska Medicine for newly diagnosed patients and patients with relapsed or refractory disease that hold the promise of increasing the rate of remission and finding a cure for all HL patients. The proportion of patients with HL, who enter into remission and stay in remission for years, has increased over the last three decades. See what clinical trials related to lymphomas are going on right now. Talk to your care team to see if there are clinical trials you may qualify for.

Nebraska Medicine is also part of the National Institutes of Health/National Cancer Institute Bone Marrow Transplant Clinical Trials Network – a consortium transplant centers across the country that collaborate on clinical trials to derive data from a larger population of patients and to allow for greater sharing of information between centers. Through this network, doctors can study and refine their techniques to diagnose, treat and follow patients to provide them with optimal care. See what bone marrow clinical trials are offered here.